|
WO2006124161A1
|
|
Sustained release l-arginine formulations and methods of manufacture and use
|
|
WO2006081147A1
|
|
Methods of treating various conditions by administration of sustained release l-arginine
|
|
CN101184510A
|
|
Methods of treating various conditions by administration of sustained release l-arginine
|
|
WO2005035001A1
|
|
Sustained release l-arginine formulations and methods of manufacture and use
|
|
NZ539672A
|
|
Sustained release L-arginine-formulations and methods of manufacture and use
|
|
CN1731985A
|
|
Sustained release l-arginine formulations and methods of manufacture and use
|
|
AU2003231252A1
|
|
Methods and compositions for the treatment and prevention of intermittent claudication or alzheimer's disease
|
|
WO0056328A1
|
|
Increasing cerebral bioavailability of drugs
|
